Condition
Geographic Atrophy
Ophthalmology
Overview
A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Geographic Atrophy
- Topic type
- Condition
- Category
- Ophthalmology
- MeSH classification
- C11.768.585.439.122
Preparing for an appointment about Geographic Atrophy
If you are speaking with a healthcare professional about Geographic Atrophy, it can help to prepare a few details in advance.
- Write down your symptoms and when they started.
- Bring details of any medicines, supplements or previous treatments.
- Ask what tests or assessments may be needed.
- Ask what treatment or management options may be suitable.
- Ask when you should seek urgent medical help or follow-up care.
Finding care related to Geographic Atrophy
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Geographic Atrophy
No clinics are currently linked directly to Geographic Atrophy on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.